The hardest part of living with metastatic triple-negative breast cancer, a cancer that has spread to other parts of the body ...
Liver cancer treatment has changed a lot in five years, and how it changed tells you a lot about where it’s going. Most of ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...
The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
African American patients with newly diagnosed multiple myeloma were less likely than White patients to receive drugs that ...
American Society for Radiation Oncology (ASTRO) published its first clinical practice guideline on radiation therapy for ...
Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...
In the phase 3 MAVERICK trial, people with small cell lung cancer who had regular brain MRIs instead of preventive whole-brain radiation kept their memory and thinking intact longer, with no clear ...
A Phase 3 trial of firmonertinib did not meet its main goal in a hard-to-treat lung cancer subtype, though the drug caused ...
The trial met its primary end point of progression-free survival in patients with an International Prognostic Index (IPI) ...
Katie Parrinello was diagnosed with primary mediastinal B-cell lymphoma at 29, reached remission four days before turning 30 ...
Ameluz photodynamic therapy is the first light-based treatment the FDA has approved for a skin cancer. Here's who it's for, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results